PolyPeptide Group AG
SIX:PPGN
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
14.19
34.4
|
Price Target |
|
We'll email you a reminder when the closing price reaches CHF.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one PPGN stock under the Base Case scenario is 24.99 CHF. Compared to the current market price of 27.95 CHF, PolyPeptide Group AG is Overvalued by 11%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
PolyPeptide Group AG
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for PPGN cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
PolyPeptide Group AG
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
PolyPeptide Group AG
Balance Sheet Decomposition
PolyPeptide Group AG
Current Assets | 292.6m |
Cash & Short-Term Investments | 48.5m |
Receivables | 68.9m |
Other Current Assets | 175.2m |
Non-Current Assets | 372.3m |
Long-Term Investments | 6.2m |
PP&E | 334m |
Intangibles | 16.5m |
Other Non-Current Assets | 15.6m |
Current Liabilities | 183.6m |
Accounts Payable | 41.6m |
Other Current Liabilities | 142m |
Non-Current Liabilities | 121.4m |
Long-Term Debt | 68.5m |
Other Non-Current Liabilities | 52.9m |
Earnings Waterfall
PolyPeptide Group AG
Revenue
|
327.3m
EUR
|
Cost of Revenue
|
-297m
EUR
|
Gross Profit
|
30.3m
EUR
|
Operating Expenses
|
-44.9m
EUR
|
Operating Income
|
-14.6m
EUR
|
Other Expenses
|
-14m
EUR
|
Net Income
|
-28.6m
EUR
|
Free Cash Flow Analysis
PolyPeptide Group AG
EUR | |
Free Cash Flow | EUR |
PolyPeptide is navigating a transition year in 2023, undertaking aggressive expansion with the aim to become a large-scale CDMO. They've offset COVID-19 revenues, indicating strong core business growth, and advanced key partnerships, particularly in metabolics. The product pipeline has grown, with 31 phase III projects set to ensure mid-term growth. Increased customer demand is fueling CapEx expansion, funded by planned additional financing. The company has an operational improvement plan underway, though the first half saw a sharp profitability decline due to inventory write-offs and negative cost absorption. The second half of the year is focused on fulfilling customer demand, expecting higher revenue and EBITDA, and improving operational productivity, with profitability projected to recover as the scale-up continues.
What is Earnings Call?
PPGN Profitability Score
Profitability Due Diligence
PolyPeptide Group AG's profitability score is 37/100. The higher the profitability score, the more profitable the company is.
Score
PolyPeptide Group AG's profitability score is 37/100. The higher the profitability score, the more profitable the company is.
PPGN Solvency Score
Solvency Due Diligence
PolyPeptide Group AG's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Score
PolyPeptide Group AG's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PPGN Price Targets Summary
PolyPeptide Group AG
According to Wall Street analysts, the average 1-year price target for PPGN is 32.64 CHF with a low forecast of 19.19 CHF and a high forecast of 47.25 CHF.
Dividends
Current shareholder yield for PPGN is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
PPGN Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
PolyPeptide Group AG is a contract development and manufacturing organization for clinical and approved commercial-stage peptide drug substances used in peptide-based therapeutics. The company is headquartered in Zug, Zug and currently employs 1,041 full-time employees. The company went IPO on 2021-04-29.
Officers
The intrinsic value of one PPGN stock under the Base Case scenario is 24.99 CHF.
Compared to the current market price of 27.95 CHF, PolyPeptide Group AG is Overvalued by 11%.